CARLO DENNIS J PHD 4
4 · Adamis Pharmaceuticals Corp · Filed May 27, 2022
Insider Transaction Report
Form 4
CARLO DENNIS J PHD
DirectorPresident/CEO10% Owner
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-05-25−250,000→ 0 total→ Common Stock (250,000 underlying) - Exercise/Conversion
Common Stock
2022-05-25+250,000→ 535,867 total
Holdings
- 5,883(indirect: By Children)
Common Stock
- 150,709(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents the vesting of a portion of previously granted restricted stock units (RSU), with shares of common stock to be issued following vesting of the RSUs.
- [F2]On March 1, 2017, the reporting person was granted 250,000 Restricted Stock Units. On May 25, 2022 all of these Restricted Stock Units were fully vested.